Tag Archives: COVID-19

U.S. begins effort to vaccinate young children against COVID-19

By Carl O’Donnell and Maria Caspani

(Reuters) -The United States on Wednesday began administering the COVID-19 vaccine to children ages 5 to 11, the latest group to become eligible for the shots that provide protection against the illness to recipients and those around them.

On Tuesday, the U.S. Centers for Disease Control and Prevention recommended the Pfizer Inc/BioNTech SE shot for broad use in that age group.

Only a limited number of the 15 million shots being distributed now will be available on Wednesday. They are expected to be more widely accessible at pediatrician’s offices, children’s hospitals and pharmacies next week.

The big national pharmacy chains, Walgreens Boots Alliance, CVS Health and Rite Aid are among those offering appointments for this weekend.

Virginia Commonwealth University Health received the vaccine on Tuesday but will probably not start administering it until next week because of logistics and safety protocols, Director of Pharmacy Services Rodney Stilner told Reuters.

“For us to be able to receive the vaccine and even start today would just be like, almost impossible,” he said.

While about 58% of Americans are fully vaccinated against COVID-19, some 28 million children under 12 have not been eligible until now.

The 10-microgram shot of the Pfizer/BioNTech vaccine authorized for school-age kids – a third the strength given to adolescents and adults – offers protection from the Delta variant of the virus that has led to thousands of pediatric hospitalizations.

‘MUCH EASIER, MUCH SAFER’

The vaccine, shown to be more than 90% effective at preventing symptomatic infection in children, also provides an avenue for fewer quarantines or school closures and more normal activities and freedoms.

“I think it’s going to make the issue of schools much easier, much safer,” White House chief medical adviser Dr. Anthony Fauci said in an interview with CNN on Wednesday.

Still, it remains unclear how many parents will jump at the chance. Even many who have been vaccinated themselves are more divided over whether to vaccinate their own younger children, given that severe COVID-19 is much less common for them.

There were no new safety issues in Pfizer’s study of the vaccine in thousands of children, but there is also no long-term data for its use.

The U.S. Food and Drug Administration authorized the Pfizer/ BioNTech vaccine for children aged 5 to 11 years on Friday. A few other countries, including China, are already vaccinating children. The European Union and Canadian regulators are currently considering Pfizer’s application for the vaccine in this younger age group.

So far, only Pfizer’s shot has been authorized for use in the United States for those under age 16.

Moderna Inc has delayed its request for authorization for its vaccine for children aged 6 to 11 and is waiting on an FDA review of safety data in connection with its application for 12- to 17-year old’s.

The states with the highest adult COVID-19 vaccination rates are preparing bigger pushes to get children inoculated than states where hesitancy remains strong, potentially widening the gaps in protection nationwide, public health officials and experts said.

COVID-19 vaccines have emerged as yet another issue exposing deep political fault lines in the United States that led to opposing stances on vaccinations, face covering and other pandemic restrictions in various parts of the country.

California, New York and Washington state, all led by Democratic governors who have promoted vaccination and mask-wearing, are setting up mobile sites and high-volume vaccination clinics for children, spokespeople for the public health departments of those states said.

California has also mandated that school-age children get a COVID-19 vaccine once their age group is eligible, a measure being considered in New York and Washington.

Republican state governors have largely resisted measures such as mask mandates or vaccine requirements in workplaces, schools and public venues. More than a dozen states, including Florida and Texas, have tried to block schools from imposing such requirements themselves.

(Reporting by Carl O’Donnell; additional reporting and writing by Maria Caspani; Editing by Caroline Humer, Jonathan Oatis and Bill Berkrot)

Russian regions extend workplace shutdown, Moscow to lift curbs

MOSCOW (Reuters) – Four Russian regions said on Wednesday they would extend a one-week workplace shutdown that took effect nationwide on Oct. 30 in response to a surge in COVID-19 cases, as the death toll from the country’s epidemic hit a record high.

President Vladimir Putin ordered the shutdown last month, giving regional authorities the option of extending it.

Authorities in the Kursk and Bryansk regions, which border Ukraine, the Chelyabinsk region near the Ural mountains and Tomsk in Siberia said their shutdowns would be prolonged.

“The tense epidemiological situation forces us to extend the period of non-working days by another week,” Tomsk governor Sergei Zhvachkin said in a statement. “One non-working week is not enough to stop the chain of infection.”

Russia’s daily COVID-19 death toll rose to a record 1,189 on Wednesday as the government coronavirus task force also reported 40,443 new infections in the last 24 hours.

Moscow authorities, meanwhile, said businesses there would reopen on Monday.

“The spread of the disease has stabilized in terms of its detection and its severe forms requiring hospitalization,” RIA news agency quoted the capital’s mayor, Sergei Sobyanin, as saying.

Other measures, including a requirement that companies have at least 30% of their staff work from home, would remain in place, Sobyanin said.

The health consumer watchdog in Moscow said it had recorded violations of COVID-19 regulations at more than a quarter of the businesses it inspected last week.

The Moscow region, which includes the small cities and towns surrounding the city, also said it would not prolong the shutdown.

The Novgorod region announced on Monday it was extending its shutdown by a week.

(Reporting by Gabrielle Tétrault-Farber and Gleb Stolyarov; editing by John Stonestreet)

Chinese stock up on staples after government ‘just in case’ advice prompts confusion

By Dominique Patton and Martin Quin Pollard

BEIJING (Reuters) – Beijing shoppers stocked up on cabbage, rice and flour for the winter on Wednesday, after the government urged people to keep stores of basic goods in case of emergencies, though it assured them there were sufficient supplies after some panic-buying.

The Ministry of Commerce on Monday published a seasonal notice encouraging authorities to do a good job in ensuring food supplies and stable prices ahead of the winter, following a recent spike in the prices of vegetables and a growing outbreak of COVID-19.

But the ministry’s advice to households to also stock up on daily necessities in case of emergencies prompted confusion, sending some rushing to supermarkets for extra supplies of cooking oil and rice.

China’s cabinet late on Wednesday said it would guarantee supplies of daily necessities, including meat and vegetables, and stabilize prices, state media reported.

China’s instructions also pushed up domestic edible oil futures as well as Malaysian palm oil.

“It’s going to be a cold winter, we want to make sure we have enough to eat,” said one woman loading rice on to a bicycle outside a supermarket in central Beijing.

A long line formed at the supermarket’s cabbage stall, as people bought supplies of the vegetable that is traditionally stored at home and consumed over the winter months.

But many residents said there was no need to buy more food than normal.

“Where could I stockpile vegetables at home? I get enough for my daily needs,” said a Beijing retiree surnamed Shi leaving another Beijing supermarket.

Others said they did not expect any shortages, particularly in the capital.

Government advice to residents to buy supplies ahead of the winter is issued every year, said Ma Wenfeng, an analyst at A.G. Holdings Agricultural Consulting.

“It is necessary because there is often heavy snowfall in the winter … and it seems there will be some uncertainty about the weather conditions this year. So I think this is quite a normal matter,” he said.

China’s National Meteorological Center is predicting a plunge in temperatures over the weekend in the northwest, southwest and most central and eastern regions.

China’s state broadcaster CCTV reported on Tuesday that there had been some “over-interpretation” of the ministry’s advice.

“Currently, the supply of daily necessities in various places is sufficient, and the supply should be fully guaranteed,” it quoted Zhu Xiaoliang, director of the ministry’s Department of Consumption Promotion, as saying.

Some cities including Tianjin in the north and Wuhan further south have released winter vegetables from stockpiles for sale at lower prices in supermarkets.

But some panic-buying appeared to continue on Wednesday, with several people complaining online of empty supermarket shelves, attributed largely to a growing COVID-19 outbreak.

China reported its highest number of new locally transmitted COVID-19 cases in almost three months on Wednesday, including nine new infections in Beijing, the biggest one-day increase in the capital this year.

“Even bulk rice has been stripped off (shelves),” said a resident in the southern city of Nanjing, writing on China’s microblog Weibo.

“There is uncertainty about the occurrence of the COVID-19 outbreaks. Once an outbreak occurs, people’s livelihoods will be affected. That’s why people are stocking up on winter supplies to avoid the impact of COVID-19,” said Ma at A.G. Holdings.

Chinese authorities typically respond to COVID-19 cases by locking down entire communities where they occur, restricting movement in and out of affected areas.

(Reporting by Dominique Patton and Martin Quin Pollard. Additional reporting by Beijing Newsroom. Editing by Karishma Singh, Christian Schmollinger and Nick Macfie)

COVID-19 still rages, but some U.S. states reject federal funds to help

By Andy Sullivan

(Reuters) – As the resurgent COVID-19 pandemic burns through the rural U.S. state of Idaho, health officials say they don’t have enough tests to track the disease’s spread or sufficient medical workers to help the sick.

It’s not for want of funding.

The state’s Republican-led legislature this year voted down $40 million in federal aid available for COVID-19 testing in schools. Another $1.8 billion in pandemic-related federal assistance is sitting idle in the state treasury, waiting for lawmakers to deploy it.

Some Idaho legislators have accused Washington of overreach and reckless spending. Others see testing as disruptive and unnecessary, particularly in schools, since relatively few children have died from the disease.

“If you want your kids in school, you can’t be testing,” said state Representative Ben Adams, a Republican who represents Nampa, a city of about 100,000 people in southwestern Idaho.

Meanwhile, the state is reporting the fifth-highest infection rate in the United States, at 369 confirmed cases per 100,000 people, according to the U.S. Centers for Disease Control and Prevention.

Schools in at least 14 of Idaho’s 115 districts, including Nampa, have had to close temporarily due to COVID-19 outbreaks since the start of the year, according to Burbio, a digital platform that tracks U.S. school activity.

Idaho’s experience illustrates how political ideology and polarization around the COVID-19 epidemic have played a role in the decision of mostly conservative states to reject some federal funding meant to help locals officials battle the virus and its economic fallout.

For example, Idaho was one of 26 Republican-led states that ended enhanced federally funded unemployment benefits before they were due to expire in September. Gov. Brad Little claimed that money was discouraging the jobless from returning to work. At least six studies have found that the extra benefits have had little to no impact on the U.S. labor market.

Idaho has also rebuffed $6 million for early-childhood education, as some Republicans in the state said mothers should be the primary caretakers of their children.

The state also did not apply for $6 million that would have bolstered two safety-net programs that aid mothers of young children and working families. Little’s administration said it had enough money already for those programs.

Idaho has accepted some federal COVID-19 help. In fact, the rejected funds are just a small portion of the nearly $2 billion in federal relief Idaho has spent since March 2020 to fight the virus and shore up businesses and families, state figures show.

But hundreds of millions more remain untouched. Idaho has deployed just $780 million, or 30%, of the $2.6 billion it received under the federal American Rescue Plan Act, signed into law in March.

Neighboring Washington state, by contrast, has parceled out nearly three-quarters of the $7.8 billion it received under that legislation. Washington has recorded roughly 60% as many cases per capita as Idaho since the start of the pandemic, according to the U.S. Centers for Disease Control and Prevention.

Some in Idaho are exasperated that a state of just 1.8 million people would turn down a dime of assistance when it’s struggling to tame the pandemic.

With no testing in place, nurses in Nampa schools rely mainly on parents to let them know when a child is infected, the district’s top nurse, Rebekah Burley, told the school board in September. She said she needed three or four more staffers to track existing cases and attempt to keep people quarantined.

“We’re tired, we are stressed, and something needs to change,” she said.

REJECTING FEDERAL MONEY

The refusal by red states to accept some types of federal aid that would benefit their constituents isn’t new.

For example, a dozen Republican-controlled states have rejected billions of dollars available through the landmark 2010 Affordable Health Care Act to cover more people under the Medicaid health program for the poor, which is jointly funded by the federal government and the states. Lawmakers from these places contended their states couldn’t afford to pay their share of an expansion. (Idaho initially was among them, but its voters opted in to the Medicaid expansion through a 2018 ballot referendum, bypassing state leaders.)

That same dynamic has played out during the coronavirus crisis. Since March 2020, Congress has approved six aid packages totaling $4.7 trillion under Republican and Democratic administrations, including the bipartisan CARES Act in March 2020 and the Democratic-backed American Rescue Plan Act this year.

Florida and Mississippi didn’t apply for benefits that would give more money to low-income mothers of young children. Four states, including Idaho, North Dakota and Oklahoma, opted not to extend a program that provided grocery money to low-income families with school-age kids in summer months.

Iowa, like Idaho, turned down federal money for COVID-19 testing in schools. New Hampshire rejected money for vaccinations.

Republican lawmakers in Idaho, like those elsewhere, cite concerns about local control, restrictive terms attached to some of the aid, and the skyrocketing national debt.

“We are chaining future generations to a lifetime of financial slavery,” said Adams, the Idaho legislator.

Yet even before the pandemic, Idaho long relied on Washington for much of its budget. Federal funds account for 36% of state spending in Idaho, according to the National Association of State Budget Officers, above the national average of 32%.

State officials say they have enough money to handle the COVID-19 crisis for now.

Critics say Idaho’s reluctance to use more federal aid is a symptom of its hands-off approach to COVID-19 safety. Few public schools require masks, and local leaders have refused to impose mask mandates, limits on indoor gatherings and other steps to contain the virus.

“There’s a lot of people in our legislature and some local officials who really have not taken this seriously,” said David Pate, the former head of St. Luke’s Health System, the state’s largest hospital network.

Idaho has one of the lowest vaccination rates in the nation, with only 55% of adults and teens fully immunized, compared to 67% nationally.

HOSPITALS FULL

COVID-19 is pummeling Idaho even as cases have plunged in much of the nation. Intensive-care units statewide are full, forcing hospitals to turn away non-COVID patients. At least 627 residents died of the disease in October, well above the previous monthly death toll of last winter, records show.

Idaho received $18 million through the American Rescue Plan to hire more public-health workers, but lawmakers did nothing with that money this year.

Some local public health departments say they do not have enough staff to track the virus. “We have a lot of people doing two or three jobs right now,” said Brianna Bodily, a spokesperson for the public-health agency serving Twin Falls, a southern Idaho city of 50,000. The department is working with a 12% smaller budget than last year.

Such staff shortages have contributed to a backlog of test results statewide, which the Idaho Department of Health and Welfare says is hurting its ability to provide an up-to-date picture of the disease’s prevalence.

With funding bottled up in the state capitol, Little, the governor, announced in August that he would steer $30 million from a previous round of COVID-19 aid to school testing.

The Nampa school district has requested some of that money but has yet to set up a testing program, spokeswoman Kathleen Tuck said. Roughly 20% of the district’s students were not attending class regularly in the first weeks of the school year due to outbreaks, according to superintendent Paula Kellerer.

Nampa resident Jaci Johnson, a mother of two children, ages 10 and 13, said she and other parents have been torn over whether to send their children to class, due to the potential risk.

“Do we feed our kids to the lions, or do we keep them home and make them miserable?” Johnson said.

(Reporting by Andy Sullivan; Editing by Scott Malone and Marla Dickerson)

From Boeing to Mercedes, a U.S. worker rebellion swells over vaccine mandates

By Tina Bellon and Eric M. Johnson

AUSTIN/SEATTLE (Reuters) – In Wichita, Kansas, nearly half of the roughly 10,000 employees at aircraft companies Textron Inc and Spirit AeroSystems remain unvaccinated against COVID-19, risking their jobs in defiance of a federal mandate, according to a union official.

“We’re going to lose a lot of employees over this,” said Cornell Beard, head of the local Machinists union district. Many workers did not object to the vaccines as such, he said, but were staunchly opposed to what they see as government meddling in personal health decisions.

The union district has hired a Texas-based lawyer to assist employees and prepare potential lawsuits against the companies should requests for medical or religious exemptions to vaccination be denied.

A life-long Democrat, Beard said he would no longer vote for the party. “They’ll never get another vote from me and I’m telling the workers here the same thing.”

The clock is ticking for companies that want to continue gaining federal contracts under an executive order by Democratic President Joe Biden, which requires all contractor employees be fully vaccinated against COVID-19 by Dec. 8.

That means federal contract workers need to have received their last COVID-19 shot at least two weeks before the deadline to gain maximum protection, according to U.S. government guidance.

With a three-week gap between shots of the Pfizer/BioNTech vaccine, workers must get the first jab by Wednesday. If the government holds fast to its deadline, it is already too late to choose Moderna’s vaccine, which is given in two doses four weeks apart. Workers could opt to get Johnson & Johnson’s single-shot vaccine until Nov. 24 to meet the deadline.

Vaccines remain by far the most effective way to prevent COVID-19 hospitalizations and deaths, particularly faced with the extremely contagious Delta variant of the virus that can cause infections even among those fully vaccinated.

Despite vocal opposition from some, vaccine mandates have been effective at shrinking the rates of the unvaccinated and convincing the reluctant to roll up their sleeves.

Several big employers such as Procter & Gamble, 3M and airlines including American Airlines and JetBlue have imposed mandates. In some industries, including among food workers, unions have supported vaccine requirements.

But the mandate has stirred protests from workers in industries across the country, as well as from Republican state officials.

Opposition to the mandate could potentially lead to thousands of U.S. workers losing their jobs and imperil an already sluggish economic recovery, union leaders, workers and company executives said.

More legal clashes are likely over how companies decide requests for vaccination exemptions.

For the companies, time is getting tight, though the Biden administration has signaled federal contractors will not have to immediately lay off unvaccinated workers who miss the Dec. 8 deadline.

Under government guidance published on Monday, companies will have flexibility over how to implement the mandate, which may allow them to avoid mass firings.

“A covered contractor should determine the appropriate means of enforcement with respect to its employee,” the guidance said.

For Boeing Co in the United States, more than 7,000 workers have applied for religious exemptions and around 1,000 are seeking medical exemptions, people familiar with the matter told Reuters. That amounts to some 6% of the plane maker’s roughly 125,000 U.S employees.

‘ILLEGAL, IMMORAL AND IMPRACTICAL’

At a rally last week outside Boeing property in Auburn, south of Seattle, many of the three dozen workers gathered in driving rain said they would rather be escorted off Boeing property on Dec. 8 than take a vaccine. Others said they would pursue early retirement.

“The mandate is illegal, immoral and impractical,” said one veteran Boeing program analyst who attended the rally. “We are standing together against a company and government trampling on our rights.”

Many legal experts have said vaccine mandates in the interest of public health are legal. The U.S. Supreme Court has rejected several challenges to mandates, with the high court last week turning away a healthcare worker who sought a religious exemption to a COVID-19 vaccine mandate.

The rebellion has put Boeing executives in a bind. The company could lose skilled staff, but must comply with a presidential order.

A Boeing spokesperson said the company was committed to maintaining a safe working environment for its employees.

The order’s provision for religious and medical exemptions is causing more tension.

Two Textron workers who requested religious exemptions told Reuters the company’s human resources representatives quizzed them on the name of their church leaders and asked detailed questions about their faith.

Textron declined to respond to questions, but in a statement said it was obligated to comply with Biden’s order and was taking steps to do so.

“Employees who are unable to receive the COVID-19 vaccination due to a medical condition or sincerely held religious belief are being provided an opportunity to request an accommodation from this requirement,” Textron said.

Spirit AeroSystems did not respond to a request for comment.

Raytheon Technologies’ CEO Greg Hayes last week warned the U.S. defense firm will lose “several thousand” employees because of the mandate.

A group representing FedEx Corp, United Parcel Service Inc and other cargo carriers said it would be virtually impossible to have all their workforces vaccinated by the deadline.

Some companies have imposed vaccine mandates even absent immediate government regulation.

Mercedes-Benz USA, the U.S. unit of German carmaker Daimler AG which is not a U.S. government contractor, told employees in an October email seen by Reuters that proof of vaccination against COVID-19 would become a condition of employment beginning Jan. 4.

The carmaker said it implemented the move in anticipation of a separate U.S. government vaccine mandate that would apply to businesses with at least 100 employees, affecting some 80 million workers nationwide.

Less than half of the company’s workers at U.S. import processing centers are vaccinated and many refuse to get a shot, according to a source familiar with the matter.

Mercedes USA in a statement said it had given employees 90-day notice to fulfill the requirement, adding that two thirds of its U.S. employees – not including factory workers in Alabama – have provided proof of vaccination to date.

“We expect that the vast majority of our employees will provide proof of vaccination before the deadline,” the company said.

(Reporting by Tina Bellon in Austin, Texas and Eric M. Johnson in Seattle, Washington; Editing by Joe White and Bill Berkrot)

Factbox – Latest on the worldwide spread of the coronavirus

(Reuters) – New York City Mayor Bill de Blasio declared his coronavirus vaccination order for emergency responders a success, with no disruption to city services, despite a sickout by some firefighters who officials said were protesting the mandate.

DEATHS AND INFECTIONS

EUROPE

* Leaders of the world’s 20 biggest economies endorsed in Rome a global minimum tax aimed at stopping big business from hiding profits in tax havens, and also agreed to get more COVID vaccines to poorer nations.

* Britain will send 20 million vaccine doses to developing countries by the end of this year in what Prime Minister Boris Johnson will tell other world leaders is a much needed step to speed up the post-pandemic economic recovery.

* President Vladimir Putin said Russia may need the army’s help to build field hospitals for COVID-19 patients as the country battles a surge in infections that has led to a nationwide workplace shutdown.

* The Netherlands will impose new coronavirus restrictions this week in a bid to curb a recent surge in infections.

* Latvia has received shipments of emergency medical equipment from the Netherlands, Finland, Hungary and Sweden as it fights the worst surge in new COVID-19 cases in the European Union amid a low take-up of vaccinations.

AMERICAS

* The Biden administration said a planned rule requiring private-sector employers with 100 or more employees to mandate COVID-19 vaccines or regular testing will be published in the coming days.

* The United States is rolling out Pfizer/BioNTech COVID-19 vaccines for children aged 5 to 11 this week, but most of the 15 million shots being shipped initially are unlikely to be available before next week.

* U.S. states with the highest adult vaccination rates against COVID-19 are planning a big push to get children inoculated compared to states where hesitancy remains strong, potentially widening the gaps in protection nationwide, public health officials and experts said.

ASIA-PACIFIC

* Thailand, Australia and Israel eased international border restrictions significantly Monday for the first time in 18 months, offering a broad test of demand for travel worldwide amid the pandemic.

* New Zealand will extend coronavirus curbs for another week in its largest city of Auckland but ease some after that, with the country logging another day of record new infections.

* A declassified U.S. intelligence report saying it was plausible that the COVID-19 pandemic originated in a laboratory is unscientific and has no credibility, a Chinese foreign ministry spokesman said.

* Indonesia has approved the Sinovac Biotech vaccine for children aged 6-11, its food and drug agency said, following the U.S. Food and Drug Administration’s approval of the Pfizer/BioNTech vaccine for younger children.

MIDDLE EAST AND AFRICA

* The United Arab Emirates has approved for emergency use the Pfizer-BioNtech vaccine for children aged 5-11, the health ministry said in a statement carried by state media.

MEDICAL DEVELOPMENTS

* Novavax Inc expects regulators in India, the Philippines and elsewhere to make a decision on its COVID-19 vaccine within “weeks,” its chief executive told Reuters, after the shot received its first emergency use authorization from Indonesia.

ECONOMIC IMPACT

* Global equity markets rose at the start of a big week for central bank meetings, helped by bets of fiscal stimulus in Japan and undeterred by concerns of future interest rate hikes that have tempered bonds.

(Compiled by Aditya Soni and Federico Maccioni; Edited by Angus MacSwan and Arun Koyyur)

U.S. vaccines for children plan fully operational next week, White House says

By Ahmed Aboulenein and Alexandra Alper

WASHINGTON (Reuters) -The United States is rolling out Pfizer/BioNTech COVID-19 vaccines for children aged 5 to 11 this week, but most of the 15 million shots being shipped initially are unlikely to be available before next week, the White House said on Monday.

Millions of doses specifically formulated for children of that age group will start arriving at distribution centers over the next few days, White House coronavirus response coordinator Jeff Zients said, and the federal government has purchased enough supply for all eligible 28 million children.

“The whole plan is based on Pfizer vaccines,” Zients told reporters at a briefing. “So the bottom line is there’s plenty of supply of the Pfizer vaccine and we look forward to parents having the opportunity to vaccinate their kids.”

The U.S. Food and Drug Administration on Friday authorized the Pfizer Inc and BioNTech SE coronavirus vaccine for children aged 5 to 11 years, making it the first COVID-19 shot for young children in the United States.

The U.S. Centers for Disease Control and Prevention still needs to advise on how the shot should be administered, which will be decided after a group of outside advisers discuss the plan on Tuesday.

Following the CDC’s decision, parents will be able to visit vaccines.gov and filter locations offering the vaccine for the children, Zients said.

(Reporting by Ahmed Aboulenein and Alexandra Alper; Additional reporting by Susan Heavey in Washington and Michael Erman in New Jersey; Editing by Alison Williams)

New York prepares for fallout from vaccine mandate resisted by many police, firefighters

NEW YORK (Reuters) – New York woke up on Monday to its first full workday under Mayor Bill de Blasio’s order that all city workers be vaccinated for COVID-19, with many police officers and firefighters still refusing the shot and one labor leader calling the mandate a recipe for disaster.

De Blasio, a Democrat who announced the mandate less than two weeks ago, has assured the city of 8.8 million people that officials could handle any shortage of police, firefighters or sanitation workers through schedule changes and overtime.

“Another great uptick to report. @FDNY EMS vaccine rates are up to 87%,” Danielle Filson, a press deputy for de Blasio, tweeted on Sunday night.

The percentage of inoculated police officers and firefighters is below that of other city employees, and union leaders say de Blasio will be to blame if emergency services are left in disarray in the largest U.S city.

“We need everyone we can to keep the city running and keep it safe. We’re trying to avoid what is going to be an inevitable disaster by design on Monday morning,” Andrew Ansbro, president of the Uniformed Firefighters Association, told a news conference on Friday.

Union leaders say their members were given only nine days to comply with the mayor’s vaccination deadline and that workers who have already been ill with COVID-19 should be granted an exemption. That includes some 70% of firefighters, Ansbro said.

The dispute is the latest nationwide over vaccine mandates that have been increasingly imposed by political leaders, including President Joe Biden, to help stem the spread of the highly contagious Delta variant. Police officers and firefighters in Chicago and Los Angeles have also pushed back hard.

New York City health officials say that while research has yet to determine the degree and length of immunity from COVID-19 following an infection and illness, experts agree that vaccines can afford additional protection.

De Blasio has forecast that vaccination rates for city workers would continue to rise significantly.

The mayor said similar deadlines for other New York state and city workers prompted a rush for last-minute shots as reality set in that paychecks were about to stop coming.

Legal challenges by police and fire unions in New York City and elsewhere have so far been unsuccessful, with state and federal courts reluctant to overturn vaccine mandates.

(Reporting by Peter Szekely and Trevor Clifford in New York; Writing and additional reporting by Dan Whitcomb; Editing by Peter Cooney)

G20 wants 70% of world vaccinated by mid-2022, sets up pandemic task force

By Jan Strupczewski and Andrea Shalal

ROME (Reuters) -Finance and health ministers from the world’s 20 biggest economies (G20) said on Friday they would take steps to ensure 70% of the world’s population is vaccinated against COVID-19 by mid-2022 and created a task force to fight future pandemics.

They could not reach agreement on a separate financing facility proposed by the United States and Indonesia, but said the task force would explore options for mobilizing funds to boost pandemic preparedness, prevention and response.

“To help advance toward the global goals of vaccinating at least 40 percent of the population in all countries by the end of 2021 and 70 percent by mid-2022 … we will take steps to help boost the supply of vaccines and essential medical products and inputs in developing countries and remove relevant supply and financing constraints,” the G20 ministers said in a statement.

The previous goal had eyed vaccinating 70% of the world’s population by the autumn of 2022.

“We establish a G20 Joint Finance-Health Task Force aimed at enhancing dialogue and global cooperation on issues relating to pandemic prevention, preparedness and response, promoting the exchange of experiences and best practices, developing coordination arrangements between Finance and Health Ministries, promoting collective action, assessing and addressing health emergencies with cross-border impact and encouraging effective stewardship of resources,” the statement said.

The ministers said they were setting up the new body because the COVID-19 pandemic had exposed significant shortcomings in the world’s ability to coordinate its response.

They pledged to support “all collaborative efforts” to provide access to safe, affordable, quality and effective vaccines, therapeutics, diagnostics, and personal protective equipment, particularly in low- and middle-income countries.

To reach the vaccination goals, they said they would work to boost the supply of vaccines and essential medical products and inputs in developing countries, while removing constraints on supply and financing, but gave no specific details.

Global Citizen, an international advocacy group, welcomed the earlier target date, but said the world needed “a battle plan” that mapped out how to get there, greater transparency how many doses were being produced where, when and for whom, and a clear understanding of where there were gaps.

“It’s no longer the time for statements of intentions. Now is the time for our leaders to act,” said the group’s vice president, Friederike Roder.

The ministers also called for boosting the resilience of supply chains through voluntary technology transfer hubs, such as newly established mRNA Hubs in South Africa, Argentina and Brazil, and through joint production and processing agreements.

The call for a voluntary mRNA technology transfer means that talks on the idea of a temporary waiver of intellectual property rights on COVID-19 vaccines and therapies – originally proposed by South Africa and India and now championed by the United States – remain stuck at the World Trade Organization.

German Finance Minister Olaf Scholz said the G20 had not discussed patents.

“We have a lot of vaccines available worldwide but the reality is there are still areas in the world where the share of those vaccinated is very low,” Scholz told journalists on the sidelines of the summit.

(Reporting by Andrea Shalal and Jan Strupczewski; Editing by Nick Macfie and Alistair Bell)

Russia says at least 44,265 people died from COVID-19 in Sept

MOSCOW (Reuters) – At least 44,265 people died in Russia in September due to the coronavirus and related causes, taking the toll to around 462,000 since the pandemic began, state statistics service Rosstat said on Friday.

The figure was down from a peak of 51,044 in July, although infections and fatalities began to surge again in the second half of September and have repeatedly touched record levels this month, leading authorities to reintroduce stricter health restrictions.

The overall COVID-19 death toll reported by Rosstat is almost double the figure of 236,220 published by the Russian coronavirus task force earlier on Friday.

Authorities explain the discrepancy by the fact that the task force reports deaths from COVID-19 on a daily basis that do not need additional confirmation from medical examiners, whereas Rosstat publishes full data on a monthly basis.

Some epidemiologists say that measuring excess mortality is the best way to assess the death toll during a pandemic.

Based on the new data, Reuters calculated that the number of excess deaths in Russia between April 2020 and September 2021 was more than 632,000 in comparison with the average mortality rate in 2015-2019.

Authorities have blamed the latest surge on the more virulent Delta variant and on popular reluctance to take up the Russian-made Sputnik V vaccine.

(Reporting by Gleb Stolyarov and Andrey Ostroukh; Writing by Alexander Marrow; Editing by Mark Trevelyan)